These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 81230)

  • 21. Characterization of immunogenic properties of haptenated liposomal model membranes in mice.
    van Houte AJ; Snippe H; Peulen GT; Willers JM
    Immunology; 1981 Feb; 42(2):233-9. PubMed ID: 6161886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of liposomal model membrane composition on immunogenicity.
    Dancey GF; Yasuda T; Kinsky SC
    J Immunol; 1978 Apr; 120(4):1109-13. PubMed ID: 641340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulation with liposomes: the immune response elicited by liposomes with entrapped dichloromethylene-diphosphonate and surface-associated antigen or hapten.
    Claassen E; Kors N; van Rooijen N
    Immunology; 1987 Apr; 60(4):509-15. PubMed ID: 2953668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
    Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
    J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of antibody directed cytotoxic liposomes by CD3 on human T cells.
    Gray AG; Morgan J; Linch DC; Huehns ER
    Clin Exp Immunol; 1988 Apr; 72(1):168-73. PubMed ID: 3260836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor.
    Fuson EW; Cole AJ; Hubbard RA
    J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
    Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J
    Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressor T cell circuits in contact sensitivity. III. A monoclonal T cell hybrid-derived suppressor factor specifically suppresses local DTH transfer by a DNP-specific T cell clone.
    Miller SD; Jenkins MK
    J Immunol; 1986 Mar; 136(5):1571-8. PubMed ID: 2419406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental verification of a model of complement-dependent immune lysis of liposomes].
    Iarkov SP; Skopinskaia SN
    Biofizika; 2009; 54(3):459-63. PubMed ID: 19569506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.
    Lobo PI; Spencer CE
    J Clin Invest; 1989 Jan; 83(1):278-87. PubMed ID: 2463268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid vesicle-cell interactions. III. Introduction of a new antigenic determinant into erythrocyte membranes.
    Martin FJ; MacDonald RC
    J Cell Biol; 1976 Sep; 70(3):515-26. PubMed ID: 60342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quenching of fluorescein-conjugated lipids by antibodies. Quantitative recognition and binding of lipid-bound haptens in biomembrane models, formation of two-dimensional protein domains and molecular dynamics simulations.
    Ahlers M; Grainger DW; Herron JN; Lim K; Ringsdorf H; Salesse C
    Biophys J; 1992 Sep; 63(3):823-38. PubMed ID: 1420916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An alternative procedure for the preparation of immunogenic liposomal model membranes.
    Kinsky SC; Loader JE; Benson AL
    J Immunol Methods; 1983 Dec; 65(3):295-306. PubMed ID: 6418820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of hapten-sensitized liposomes with cells bearing hapten-specific receptors.
    Hashimoto K; Inoue K; Nojima S; Tadakuma T; Yasuda T
    J Biochem; 1983 Dec; 94(6):2009-14. PubMed ID: 6671976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and dynamical aspects of membrane immunochemistry using model membranes.
    Brûlet P; McConnell HM
    Biochemistry; 1977 Mar; 16(6):1209-17. PubMed ID: 191064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal vaccine carrier. Liposomes that provide T-dependent help to weak antigens.
    Garcon NM; Six HR
    J Immunol; 1991 Jun; 146(11):3697-702. PubMed ID: 2033246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antigenic structure of the plasma membranes of mouse liver cells. III. Lipid haptens].
    Iakimenko EF; Khramkova NI; Rudinskaia TD
    Tsitologiia; 1977 May; 19(5):345-51. PubMed ID: 70096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of effector functions of human K-cells and monocytes by antigen density of the target cells.
    Ohlander C; Larsson A; Perlmann P
    Scand J Immunol; 1981; 13(6):503-10. PubMed ID: 6171867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.